GE HealthCare Technologies Inc.
GEHC
Clasificación en acciones
#770
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Precio por acción
$69.86
Última sincronización: 2026-10-20
Capitalización bursátil
$31.56B
Cambio (1 día)
0.15%
Cambio (1 año)
-8.19%
País
US
Comercio GE HealthCare Technologies Inc. (GEHC)
Categoría
Healthcare
Ratio P/E de GE HealthCare Technologies Inc. (GEHC)
Ratio P/E al October 2026 TTM: 19.68
Según los últimos informes financieros y el precio de las acciones de GE HealthCare Technologies Inc., el P/E actual (TTM) de la empresa es 19.68. Al final de 2024, la empresa tenía un P/E de 17.89.
Historial del ratio P/E de GE HealthCare Technologies Inc. desde 2019 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 19.68 | -11.73% |
| 2025 | 22.29 | 24.60% |
| 2024 | 17.89 | -20.27% |
| 2023 | 22.44 | 62.22% |
| 2022 | 13.83 | 13.91% |
| 2021 | 12.14 | 516.21% |
| 2020 | 1.97 | -88.99% |
| 2019 | 17.90 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 64.40 | 227.32% |
AU
|
|
| 44.30 | 125.16% |
US
|
|
| -47.78 | -342.82% |
US
|
|
| -123.90 | -729.71% |
US
|
|
| - | - |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.